UK’s First Real-World Evidence Guideline Targets Randomized Trials

 
• By Vibha Sharma

The UK Medicines and Healthcare products Regulatory Agency is developing a series of guidance documents on general points to consider when planning a trial to generate real-world evidence. The first document in this series focuses on prospective randomized trials.

Real world data
Randomized trials using RWD are most likely to be considered for label changes • Source: Shutterstock

More from Real-World Evidence

More from Clinical Trials